# Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

Study · id `cardio:ct-nct02869009` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02869009](<https://clinicaltrials.gov/study/NCT02869009>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02869009

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3000 participants.

## Technical summary

Registry record NCT02869009. Randomized; no masking; primary purpose treatment. Start 2016-11 (actual); primary completion 2022-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 3000 participants (enrolled count; ClinicalTrials.gov record NCT02869009, source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)
- Started: 2016-11 (actual) (ClinicalTrials.gov record NCT02869009, source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)
- Primary completion: 2022-10-31 (actual) (ClinicalTrials.gov record NCT02869009, source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)
- Completion: 2022-10-31 (actual) (ClinicalTrials.gov record NCT02869009, source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02869009, source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02869009-2022-12-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
- Acronym: ATAMIS
- Condition: Ischemic Stroke
- Intervention (Drug): clopidogrel
- Intervention (Drug): Aspirin
- Lead sponsor: General Hospital of Shenyang Military Region
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial (`cardio:pubmed-38466274`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS (`cardio:pubmed-39248249`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early Neurologic Deterioration and Efficacy of Dual Antiplatelet in Anterior Versus Posterior Circulation Stroke (`cardio:pubmed-39846303`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 57ebcfcda502ea13f0643d31a4b8062af1b7032cb47589b15120ebd83e9556e6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
